Release Date: 20/11/09 16:46 Summary: ASX Circular: Reorganisation of Capital Price Sensitive: No Download Document 16.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%